PTPN2 and neoplasm: Strikingly, the repression of tumour growth by PTPN2‐deficient HER‐2 CAR T cells persisted long after HER‐2 tumours had been eradicated, so that approximately half of all mice were alive for longer than 200 days with the remaining half succumbing to tumours (Fig 5A).